The State of Private Equity in Dentistry in 2025

Private equity’s grip on dentistry is redefining its priorities and models, and 2025 has introduced fresh regulatory, operational, and strategic pivots worth paying attention to. This week, Dentistry 411 shares a synthesis of the latest PE data and trends along with a critical lens on what matters most right now for dental professionals. 

1. Regulatory Crackdowns Are No Longer Idle Threats 

State lawmakers are dialing up scrutiny on private equity in healthcare, and dentistry is clearly in the crosshairs. California’s recent bill expansion gives the state attorney general broader authority to intervene when corporate ownership starts to cross the line into clinical interference. Pennsylvania followed suit with similar powers to block questionable mergers and acquisitions. 

Dentists in PE-backed groups, especially those in leadership, need to stay sharply aware of how billing, coding, and clinical decision-making are handled. Regulators are actively drawing the line between management services and clinical control. If you’re in a DSO with PE involvement, start asking compliance questions now. This kind of oversight is unlikely to go away and may only intensify. 

2. Oral Surgeons Remain a Hot Commodity 

Oral and maxillofacial surgery continues to attract strong PE interest. This trend isn’t new, but its persistence is telling. High revenue per procedure, growing demand for surgical services, and the ability to operate in standalone surgical centers make oral surgery practices particularly appealing to investors seeking strong returns. 

If you’re in this specialty, you already know you’re a target. But high demand cuts both ways. Valuation multiples may remain high, but buyers are also more selective. Sellers should be prepared for more due diligence and longer transaction cycles as investors become more cautious in light of extended hold periods (more on that below). 

3. Funding Is Flowing, But It’s Shifting Downstream 

Several DSOs secured new PE funding in 2025, including Blue Cloud Pediatric Surgery Centers and Motor City Dental Partners. Notably, the investor appetite seems to be shifting toward smaller DSOs and platform-building opportunities, rather than large roll-ups. 

For dentists running smaller multi-site groups or thinking of forming one, this is an opening. Investors are looking for regional platforms they can scale. That means a smaller DSO with sound operations, clean books, and a well-differentiated patient base might be more attractive now than in previous years, especially as competition in larger, saturated DSO markets has intensified. 

4. PE Is Digging Deeper Into the DSO Ecosystem 

Smaller DSOs are now the new frontier for PE, and this trend reflects a more disciplined investment strategy. Big-name consolidators have largely built out their portfolios. Now, mid-market and lower-middle-market DSOs are the next phase of aggregation

Expect more nuanced deal structures, often involving partial buyouts, earn-outs, and co-ownership models that keep founding dentists tied in longer. This can be a positive if structured correctly, as it encourages operational continuity and aligns incentives. But it also requires more financial literacy and legal clarity from sellers. 

5. PE Penetration in Dentistry Is Accelerating 

The percentage of dentists affiliated with private equity-backed organizations has nearly doubled in six years. Dentistry is no longer a cottage industry of independent solo practices. The profession is consolidating quickly. 

For general practitioners, the pressure to join larger networks is growing. Whether that pressure comes from reimbursement constraints, hiring struggles, or simply administrative burnout, PE-backed DSOs often offer a path to stability. Still, it’s not a one-size-fits-all solution. Autonomy, clinical culture, and long-term compensation are all variables that require close scrutiny in these partnerships. 

6. Longer Hold Periods May Complicate Exit Strategies 

2024 analysis showed that PE firms are holding onto dental assets for longer than expected. This is largely due to a combination of high acquisition costs, slower EBITDA growth, and market uncertainties. It also reflects a broader shift in the PE industry toward value creation over quick flips. 

For practice owners or partners considering a sale, this has serious implications. The idea of a “quick exit” after a recapitalization is increasingly outdated. Be prepared for a longer operational partnership with investors. Know what the second and third recap looks like. Ensure you understand how decisions will be made once the honeymoon phase is over. 

PE in Dentistry Is Maturing 

The private equity playbook in dentistry is becoming more sophisticated, but also more constrained. Regulatory scrutiny, longer hold times, and more strategic acquisitions mean the Wild West phase of consolidation is winding down. What’s emerging is a more structured, slower-burning form of growth. 

If you’re navigating this space, as a solo owner, specialist, or DSO leader, you need to look beyond headline valuations. Focus on governance, compliance, post-deal integration, and the real economics of the deal. Private equity can still be a powerful engine for growth and liquidity, but only if you enter with eyes open and a firm grip on your clinical and operational values. 

SOURCES: CDAPA HouseBecker’sTPGBusinessWireBecker’sADAPitchBook